INITIAL RESULTS FROM UTERINE FIBROID EMBOLIZATION FOR SYMPTOMATIC LEIOMYOMATA

Authors

Abdul Majid Kuwait Teaching Hospital Peshawar
Ambareen Muhammad Kuwait Teaching Hospital Peshawar
Zeenat Adil Kuwait Teaching Hospital Peshawar
Amara Haroon Durrani Institute of Kidney Diseases & Transplant , Hayatabad Medical Complex, Peshawar
Aziz Zia Kuwait Teaching Hospital Peshawar
Rida Saleem Kuwait Teaching Hospital Peshawar
Kiran Ikram MMC General Hospital Peshawar

DOI:

https://doi.org/10.70520/kjms.v18i1.633

Keywords:

Uterine fibroid embolization, leiomyomata, radiologist, hysterectomy, symptomatic

Abstract

Objective: To assess the initial results of uterine artery embolization (UAE) for symptomatic leiomyomas.

Material and Methods: This prospective cohort study was performed in the Radiology Department of Kuwait Teaching Hospital, from 1 August 2022 to 31^st July 2023, on 204 consecutively registered patients. Patients 20 yrs and above with symptomatic leiomyomata were included in the study. No upper limit for uterus or fibroid volume was kept. Patients with gynaecological malignancy, undiagnosed pelvic mass, acute pelvic infection, pregnancy, menopause, contraindication to MRI and allergy to contrast agents were excluded from the study. Follow-up evaluation was performed 3 months after the procedure to assess volume reduction, infarction rates, and symptom improvement.

Results: The ages of the patient were grouped in clusters of 10 yrs. 45.1% of the patients were found in 31-40 yrs age group. Majority of the fibroids were found in intramural location comprising 69.1%. 47.1% of the patients had single fibroid. Bleeding was resolved in 185 among 192 patients (96.3%) which means that only 7 patients were still having menorrhagia; bulk/pressure symptoms and pelvic pain was resolved in all of the patients.

Conclusion: UAE is an effective, minimally invasive, uterus-preserving treatment for symptomatic fibroids, providing significant symptom relief and improved outcomes.

Author Biography

Ambareen Muhammad, Kuwait Teaching Hospital Peshawar

Assistant Professor (Radiology)

References

1. De Bruijn AM, Lohle PN, Huirne JA, de Vries J, Twisk M, Hehenkamp WJ, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA trial. JMIR Res Protoc 2018; 7(3): e47. doi: 10.2196/resprot.8512. DOI: https://doi.org/10.2196/resprot.8512

2. Saibudeen A, Makris GC, Elzein A, et al. Pain Management Protocols During Uterine Fibroid Embolisation: A Systematic Review of the Evidence. Cardiovasc Intervent Radiol. Dec 2019;42(12):1663-1677. doi: 10.1007/s00270-019-02327-1. DOI: https://doi.org/10.1007/s00270-019-02327-1

3. Graif A, Leung DA, McKenna G, Patel KD, Holmes LE, Grilli CJ.. Evaluation of the Effect of Routine Antibiotic Administration after Uterine Artery Embolization on Infection Rates. J Vasc Interv Radiol. Aug 2020;31(8):1263-1269. doi: 10.1016/j.jvir.2020.03.026. DOI: https://doi.org/10.1016/j.jvir.2020.03.026

4. Manyonda I, Belli A-M, Lumsden M-A, Moss J, McKinnon W, Middleton LJ, et al. Uterine-artery embolization or myomectomy for uterine fibroids. N Engl J Med 2020; 383: 440–51. doi: 10.1056/NEJMoa1914735 DOI: https://doi.org/10.1056/NEJMoa1914735

5. Clements W, Ang WC, Law M, Goh GS. Treatment of symptomatic fibroid disease using uterine fibroid embolisation: an Australian perspective. Aust N Z J Obstet Gynaecol 2020; 60: 324–29. doi: 10.1111/ajo.13120. DOI: https://doi.org/10.1111/ajo.13120

6. Geary RS, Gurol-Urganci I, Kiran A, Cromwell DA, Bansi-Matharu L, Shakespeare J, et al. Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National heavy menstrual bleeding audit. BMJ Open 2019; 9(2): e024260. doi: 10.1136/bmjopen-2018-024260. DOI: https://doi.org/10.1136/bmjopen-2018-024260

7. Ye Y, Ren Y, Zeng H, He J, Zhong Z, Wu X. Characterization of calibrated gelatin sponge particles in a rabbit renal embolization model. Cardiovasc Intervent Radiol 2019; 42: 1183–91. doi: 10.1007/s00270-019-02224-7. DOI: https://doi.org/10.1007/s00270-019-02224-7

8. Hacking N, Maclean D, Vigneswaran G, Bryant T, Modi S. Uterine fibroid embolization (UFE) with optisphere: a prospective study of a new, spherical, resorbable embolic agent. Cardiovasc Intervent Radiol 2020; 43: 897–903. doi: 10.1007/s00270-020-02460-2. DOI: https://doi.org/10.1007/s00270-020-02460-2

9. Sato H, Sonomura T, Onishi S, Koike M, Tanaka R, Ueda S, et al. Comparison of uterine necrosis after uterine artery embolization with soluble gelatin sponge particles or tris-acryl gelatin microspheres in swine. Cardiovasc Intervent Radiol 2021; 44: 1780–89. doi: 10.1007/s00270-021-02905-2 DOI: https://doi.org/10.1007/s00270-021-02905-2

10. Han K, Kim SY, Kim HJ, Kwon JH, Kim GM, Lee J, et al. Nonspherical polyvinyl alcohol particles versus tris-acryl microspheres: randomized controlled trial comparing pain after uterine artery embolization for symptomatic fibroids. Radiology 2021; 298: 458–65. doi: 10.1148/radiol.2020201895. DOI: https://doi.org/10.1148/radiol.2020201895

11. Sher A, Garvey A, Kamat S, et al. Single-System Experience With Outpatient Transradial Uterine Artery Embolization: Safety, Feasibility, Outcomes, and Early Rates of Return. AJR Am J Roentgenol. Apr 2021;216(4):975-980. doi: 10.2214/AJR.20.23343.

12. Kröncke T. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus. Br J Radiol. 2023 Mar;96(1143):20220121. DOI: https://doi.org/10.1259/bjr.20220121

13. Cao M, Qian L, Zhang X, Suo X, Lu Q, Zhao H, et al. Monitoring Leiomyoma Response to Uterine Artery Embolization Using Diffusion and Perfusion Indices from Diffusion-Weighted Imaging. BioMed Res Int. 2017;2017:3805073. DOI: https://doi.org/10.1155/2017/3805073

14. Kohi MP, Spies JB. Updates on Uterine Artery Embolization. Semin Interv Radiol. 2018 Mar;35(1):48–55. DOI: https://doi.org/10.1055/s-0038-1636516

15. Ludwig PE, Huff TJ, Shanahan MM, Stavas JM. Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature. Br J Radiol. 2020 Jan;93(1105):20190551. DOI: https://doi.org/10.1259/bjr.20190551

16. Chung YJ, Kang SY, Chun HJ, Rha SE, Cho HH, Kim JH, et al. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization. Int J Med Sci. 2018;15(14):1771–7. DOI: https://doi.org/10.7150/ijms.28687

17. Sher A, Garvey A, Kamat S, Ranade M, Kim E, Patel RS, et al. Single-System Experience With Outpatient Transradial Uterine Artery Embolization: Safety, Feasibility, Outcomes, and Early Rates of Return. AJR Am J Roentgenol. 2021; 216(4):975–80. DOI: https://doi.org/10.2214/AJR.20.23343

18. Katsumori T, Miura H, Asai S. First Versus Second Uterine Artery Embolization for Symptomatic Leiomyoma. AJR Am J Roentgenol. 2017 Sep;209(3):684–9. DOI: https://doi.org/10.2214/AJR.16.17672